Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
JAMA2022Vol. 327(18), pp. 1771–1771
Citations Over TimeTop 1% of 2022 papers
Lorenz Räber, Yasushi Ueki, Tatsuhiko Otsuka, Sylvain Losdat, Jonas Häner, Jacob Lønborg, Gregor Fahrni, Juan F. Iglesias, Robert‐Jan van Geuns, Anna S. Ondracek, Maria D Radu Juul Jensen, Christian Zanchin, Stefan Stortecky, David Spirk, George C.M. Siontis, Lanja Saleh, Christian M. Matter, Joost Daemen, François Mach, Dik Heg, Stephan Windecker, Thomas Engstrøm, Iréne Lang, Konstantinos C. Koskinas, PACMAN-AMI collaborators, Maria Ambühl, Sarah Bär, Andrè Frenk, Laura Morf, Andrea Inderkum, Stefanie Leuthard, Raminta Kavaliauskaite, Emrush Rexhaj, Hiroki Shibutani, Vera Ruth Mitter, Christoph Kaiser, Manuel Mayr, Franz R. Eberli, Cróchán J. O’Sullivan, Christian Templin, Arnold von Eckardstein, Art Ghandilyan, Ravindra Pawar, Hans Jonker, Thomas M. Hofbauer, Georg Goliasch, Lia E. Bang, Rikke Sørensen, Maria Natalia Tovar Forero, Sophie Degrauwe, Tim ten Cate
Abstract
ClinicalTrials.gov Identifier: NCT03067844.
Related Papers
- → Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials(2017)16 cited
- → Normal coronary myocardial infarct is innocent or guilty? A case of ventricular septal rupture secondary to normal coronary myocardial infarction(2013)7 cited
- A GEOMETRIC MEAN IN THE FURUTA INEQUALITY(2002)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )(2017)